Master'sOpen Access

Polymorphic characteristics of enzymes that metabolize anticancer drugs

2013
0 views
0 downloads
Advisor: Doç. Dr. Yasemin Baskın

Abstract (EN)

POLYMORPHIC CHARACTERISTICS OF ENZYMES THAT METABOLIZE ANTICANCER DRUGS Arsalan AMİRFALLAH Dokuz Eylul University, Institute of Oncology, 35340 Inciraltı İzmir/TURKEY Correspondence address: arsalan.amirfallah@gmail.com Objective: 5-Fluorouracil (5-FU), the mainstay of solid tumor chemotherapy over the last 40 years, induces grade III?IV toxicities in up to 15% of patients with polymorphisms in the dihydropyrimidine dehydrogenase (DPYD), thymidylate synthase (TS), and methylenetetrahydrofolate reductase (MTHFR) genes. These toxicities include mucositis, neutropenia, nausea, diarrhea, myelosuppression, hand-foot syndrome. Aim of this study was to analyse polymorphisims charecteristics of enzymese that include in 5-FU metabolic pathway, identification of population-specific gene polymorphisms and investigation the results of treatment and observed toxicities associated with related polymophisms. Method: Eighty five pateints getting 5-FU chemotherapy were included to the study. The enzymes (DPYD, TS, MTHFR) taking place in the metabolic processes of the 5-FU, scanned at SNP level with new genaration Sequenom MassARRAY Analyzer 4 in terms of single nucleotide polymorphisms. Results: Six patients had no toxicity. Toxicities types in 79 patients were: 47 patients with hematopoietic toxicities, 18 with hand and foot syndrome, 11gastrointestinal toxicities and 3 patients with skin toxicites. MTHFR 677 C>T mutation status was; 47,1% wild type, 43,5% heterozygot, 9,4% homozygot mutant. TS 1494 ins/del mutation status was; 36,5% wild type, 38,4% heterozygot, 24,7% homozygot mutant. Allelic frequency of DIVS14G>A/G was 0.6%. DPYD 85T>C mutation status was; 47,1% wild type, 43,5% heterozygot, 9,4% homozygot mutant. There were no mutation in DPYD 2846A>T and D1679T>G/T polumorphisims. Conclusion:, Foot and hand syndrome was detected more in the patients who had MTHFR 677 C>T mutation also hematopoitik toxcities were in high range in patients with TS 1494 ins/del mutation . Determination of selected enymes polymorphic charecterestics are important in order to predict the risk of toxicity of 5-FU. To verify the relationship between toxicity and genotype population based stydies among diffrent etnic groups should be done. Key Words: 5-FU metabolic pathway, MTHFR, TS, DPYD, pharmacogenetics polymorphism

Author

Dr. Arsalan Amirfallah

How to Cite

Arsalan Amirfallah (Master Thesis). Polymorphic characteristics of enzymes that metabolize anticancer drugs, 2013, Dokuz Eylül University.

License

Tüm Hakları Saklıdır

This work is shared under the specified license terms.

More theses from Dokuz Eylül University